SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

IMS & AGM

18 Apr 2013 07:00

RNS Number : 6284C
Devro PLC
18 April 2013
 



For immediate release 18 April 2013

 

 

Devro plc

(the "Group")

 

Interim Management Statement and Annual General Meeting

Devro plc, one of the world's leading manufacturers of collagen products for the food industry, today issues the following Interim Management Statement for the period from 1 January 2013 to date, ahead of its Annual General Meeting to be held at 11.00am. Steve Hannam, Chairman of Devro, will make the following statement on current trading.

 

"Devro's global sales have continued to grow during the period. This has been underpinned by good growth in much of Europe and North America, offset by a slower start in the UK and Australia. Select has begun the year well, particularly in Germany where it continues to make good progress.

 

"The major capital investment programme in the Czech Republic is proceeding as planned, with significant additional volume scheduled to come on stream in the second half of this year in order to support further growth in 2014.

 

"As announced at the time of the 2012 preliminary results, we have now implemented the planned price increases we referred to at that time. Input costs have also risen broadly in line with our expectations.

 

"Manufacturing performance, however, has been held back by lower yields, particularly in the USA, which has restricted product available for sale and impacted unit costs.

 

"We remain confident that the Group will meet the board's expectations for the full year. Whilst profits for the first quarter of the year are below the corresponding period in 2012 due to lower production yields, remedial action has already been taken and, with the benefits of recent price rises, additional volume from extra capacity and a focus on improving production processes, we do expect stronger performance as the year progresses.

 

"Net debt and cash flow are both as expected and the financial position of Devro continues to be strong."

 

Peter Page, Chief Executive, commented "Sales continue to grow in volume and value terms across the Group and our investments in people and infrastructure will ensure we have the necessary capability to take advantage of the significant opportunities that exist."

 

ENDS

 

For further information, please contact:

 

Devro plc

Peter Page, Chief Executive

Simon Webb, Group Finance Director

 

 

 

Tel No: 0207 182 4960

 

Buchanan

Diane Stewart/ Carrie Clement/

Charles Ryland

 

 

 

Tel No: 020 7466 5000/0131 226 6150

www.buchanan.uk.com

 

Notes to Editors

 

FTSE 250 listed Devro is one of the world's leading providers of collagen casings to the food industry supplying a wide range of products and technical support to manufacturers of sausages, salamis, hams and other cooked meats. The Group employs 2,200 staff across the world and produces its casings from 5 manufacturing sites based in Scotland, Australia, the Czech Republic and the USA. Devro reported sales of £241.1 million and profit before tax (excluding pension interest) of £42.2 million for the year ended 31 December 2012. Devro is a constituent of the FTSE4Good Index Series which recognises that the company's performance meets globally recognised corporate responsibility standards.

 

Further information on Devro can be found on the company's website: www.devro.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGGUWUCUPWGBM
Date   Source Headline
4th Mar 20147:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2013
24th Feb 20146:09 pmRNSHolding(s) in Company - Amendment
7th Feb 20143:54 pmRNSHolding(s) in Company
27th Jan 201411:06 amRNSHolding(s) in Company
24th Jan 20141:04 pmRNSHolding(s) in Company
31st Dec 201312:36 pmRNSDirector/PDMR Shareholding
28th Nov 20138:29 amRNSDirector/PDMR Shareholding
25th Nov 20132:13 pmRNSBlocklisting Interim Review
14th Nov 20137:00 amRNSInterim Management Statement
15th Oct 20139:28 amRNSNotification of IMS date and Capital Markets Event
27th Sep 20135:26 pmRNSHolding(s) in Company
12th Sep 20134:46 pmRNSDirector/PDMR Shareholding
30th Aug 201311:29 amRNSTotal Voting Rights
12th Aug 20135:12 pmRNSDirector/PDMR Shareholding
31st Jul 20137:00 amRNS2013 Interim Results
30th Jul 20137:00 amRNSAppointment of Non-Executive Director
22nd Jul 201311:21 amRNSBlocklisting Application
5th Jul 201312:57 pmRNSHolding(s) in Company
2nd Jul 201310:00 amRNSInterim Results Webcast Notification
24th Jun 20137:00 amRNSPre-close trading update
18th Jun 20134:27 pmRNSHolding(s) in Company
14th Jun 20139:30 amRNSNotification of Upcoming Updates
31st May 20135:00 pmRNSTotal Voting Rights
24th May 20135:00 pmRNSBlocklisting Six Monthly Return
13th May 20133:17 pmRNSDirector/PDMR Transaction
3rd May 20133:36 pmRNSDirector/PDMR Transaction
30th Apr 201312:47 pmRNSTotal Voting Rights
23rd Apr 20134:43 pmRNSDirectors Dealings
23rd Apr 20139:24 amRNSHolding(s) in Company
23rd Apr 20137:00 amRNSSite Visit
22nd Apr 201310:34 amRNSHolding(s) in Company
18th Apr 20135:21 pmRNSResults of Annual General Meeting
18th Apr 20137:00 amRNSIMS & AGM
11th Apr 20133:32 pmRNSHolding(s) in Company
5th Apr 20133:10 pmRNSBlocklisting Application
2nd Apr 20138:06 amRNSTotal Voting Rights
28th Mar 20132:43 pmRNSHolding(s) in Company
22nd Mar 20134:35 pmRNSHolding(s) in Company
19th Mar 20134:33 pmRNSDirector/PDMR Shareholding
15th Mar 20132:00 pmRNS2012 Annual Report
14th Mar 20135:10 pmRNSDirector/PDMR Shareholding
1st Mar 20133:48 pmRNSDirector/PDMR Shareholding
26th Feb 201311:44 amRNS2012 Final Dividend Record Date Amendment
26th Feb 20137:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2012
14th Jan 201312:29 pmRNSListing Rule 9.6.14(R) Disclosure
8th Jan 20132:25 pmRNSPreliminary Results Notification
21st Dec 20122:22 pmRNSAnnual Information Update
19th Dec 20125:31 pmRNSDirector/PDMR Shareholding
18th Dec 20128:59 amRNSListing Rule 9.6.14(R) Disclosure
23rd Nov 20128:53 amRNSBlocklisting Six Monthly Return

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.